-inc-logo-1200x675.png){kind=logo}
Shares of WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY – Get Free Report) rose 8% during trading on Monday . The company traded as high as $9.13 and last traded at $9.09. Approximately 1,566 shares changed hands during mid-day trading, a decline of 98% from the average daily volume of 75,101 shares. The stock had previously closed at $8.42.
WuXi Biologics (Cayman) Stock Performance
The firm has a 50 day moving average price of $8.36 and a two-hundred day moving average price of $8.92.
WuXi Biologics (Cayman) Company Profile
WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.
The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.
Further Reading
- Five stocks we like better than WuXi Biologics (Cayman)
- 5 Tech Stocks to Buy on the July Pullback
- Is OpenAI’s IPO Delay a Warning for AI Investors?
- onsemi: What the Market Gets Wrong, You Can Get Right
- Is McCormick a Steal Ahead of Game-Changing Unilever Deal?
Receive News & Ratings for WuXi Biologics (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi Biologics (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.
-inc-logo-1200x675.png){kind=logo}
